Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
BMJ Open ; 14(1): e075614, 2024 01 31.
Article En | MEDLINE | ID: mdl-38296269

INTRODUCTION: Fast and accurate diagnosis of acute stroke is crucial to timely initiate reperfusion therapies. Conventional high-field (HF) MRI yields the highest accuracy in discriminating early ischaemia from haemorrhages and mimics. Rapid access to HF-MRI is often limited by contraindications or unavailability. Low-field (LF) MRI (<0.5T) can detect several types of brain injury, including ischaemic and haemorrhagic stroke. Implementing LF-MRI in acute stroke care may offer several advantages, including extended applicability, increased safety, faster administration, reduced staffing and costs. This multicentric prospective open-label trial aims to evaluate the diagnostic accuracy of LF-MRI, as a tool to guide treatment decision in acute stroke. METHODS AND ANALYSIS: Consecutive patients accessing the emergency department with suspected stroke dispatch will be recruited at three Italian study units: Azienda Sanitaria Locale (ASL) Abruzzo 1 and 2, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital. The estimated sample size is 300 patients. Anonymised clinical and LF-MRI data, along with conventional neuroimaging data, will be independently assessed by two external units: Marche Polytechnic University and 'G. Martino' Polyclinic University Hospital. Both units will independently adjudicate the best treatment option, while the latter will provide historical HF-MRI data to develop artificial intelligence algorithms for LF-MRI images interpretation (Free University of Bozen-Bolzano). Agreement with conventional neuroimaging will be evaluated at different time points: hyperacute, acute (24 hours), subacute (72 hours), at discharge and chronic (4 weeks). Further investigations will include feasibility study to develop a mobile stroke unit equipped with LF-MRI and cost-effectiveness analysis. This trial will provide necessary data to validate the use of LF-MRI in acute stroke care. ETHICS AND DISSEMINATION: The study was approved by the Research Ethics Committee of the Abruzzo Region (CEtRA) on 11 May 2023 (approval code: richyvgrg). Results will be disseminated in peer-reviewed journals and presented in academic conferences. TRIAL REGISTRATION NUMBER: NCT05816213; Pre-Results.


Artificial Intelligence , Stroke , Humans , Prospective Studies , Point-of-Care Systems , Stroke/diagnostic imaging , Stroke/therapy , Magnetic Resonance Imaging , Research Design , Multicenter Studies as Topic
2.
Sensors (Basel) ; 22(8)2022 Apr 14.
Article En | MEDLINE | ID: mdl-35459005

The 5th generation of mobile networks has come to the market bringing the promise of disruptive performances as low latency, availability and reliability, imposing the development of the so-called "killer applications". This contribution presents a 5G use case in the context of Structural Health Monitoring which guarantees an unprecedented level of reliability when exploited for public safety purposes as Earthquake Early Warning. The interest on this topic is at first justified through a deep market analysis, and subsequently declined in terms of public safety benefits. A specific sensor board, guaranteeing real-time processing and 5G connectivity, is presented as the foundation on which the architecture of the network is designed and developed. Advantages of 5G-enabled urban safety are then discussed and proven in the experimentation results, showing that the proposed architecture guarantees lower latency delays and overcome the impairments of cloud solutions especially in terms of delays variability.


Earthquakes , Cell Phone , Reproducibility of Results
3.
BMC Health Serv Res ; 21(1): 1170, 2021 Oct 28.
Article En | MEDLINE | ID: mdl-34711231

BACKGROUND: The COVID-19 pandemic has been recognized as a trigger for redefining supply chains at the global level, and has created an intense debate within the academic community and among policy-makers and practitioners. Among other industries, health care has been dramatically hit by the scarcity of "medical products," specifically for personal protective equipment (PPE-like), due to supply chain disruptions coupled with dramatically increased demand. We aimed to analyze how the scarcity of PPE-like during the COVID-19 pandemic has modified the behavior of decision-makers in the PPE-like supply chain at the hospital level, and to explore what changes could be implemented to cope with future PPE-like shortages. METHODS: We used an explorative approach based on semi-structured interviews with key informants in the Spanish health care industry. More specifically, we held interviews to industry experts at three hospitals in three Spanish regions to map the consequences of the COVID-19 pandemic onto the buying decision-making process. RESULTS: Different strategies were developed by decision-makers at hospitals before, during, and after the first wave of the COVID-19 pandemic in Spain. Our paper offers two main findings: a) decision-makers changed their purchasing behavior from a cost main driver to guaranteeing the availability of supplies; b) they supported the idea of giving more "strategic autonomy" to Spain or Europe through back and nearshoring decisions. CONCLUSIONS: This paper could be of interest to health care management at the national, regional, and hospital levels, as well as for policy-makers, since it could help to establish and configure policies to support the sourcing of medical products (specifically PPE-like) to anticipate potential supply disruptions. Our paper contributes to the limited existing literature on how purchasing strategies at the decision-maker level and supply vary in the health care industry when a public health crisis appears, and what potential solutions might be for policy-makers and practitioners involved in the health care industry.


COVID-19 , Personal Protective Equipment , Decision Making , Hospitals , Humans , Pandemics , SARS-CoV-2
...